CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income was $2.26 billion, or $1.75 per share, compared to a net loss of $3.4 billion, or $2.59 per share, last year. Adjusted EPS was $2.21. For the full year of 2023, the company […]
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today. Total revenues increased 10.6% year-over-year to $89.8 billion. Net income was $2.26 billion, or $1.75 per share, compared to a net loss of $3.4 billion, or $2.59 per share, last year. Adjusted EPS was $2.21. For the full year of 2023, the company […]
CVS Health Corporation (NYSE: CVS) reported third quarter 2023 earnings results today.
Total revenues increased 10.6% year-over-year to $89.8 billion.
Net income was $2.26 billion, or $1.75 per share, compared to a net loss of $3.4 billion, or $2.59 per share, last year. Adjusted EPS was $2.21.
For the full year of 2023, the company expects GAAP EPS of $6.37-6.61 and adjusted EPS of $8.50-8.70.
